Brosmed was founded in Songshan Lake, Guangdong province in China in 2012, focusing on the development and production of vascular interventional balloon catheters.
The company headquartered is based in Dongguan, Guangdong, with European headquarters in Netherlands, and offices in the United States and India, and parts production base in Hunan Province.
The company use leading balloon catheter technology, has 61 domestic and foreign registration certificates (including CFDA, FDA, CE, Japan, etc.) in the fields of coronary PTCA, peripheral PTA balloon catheter, vascular access, etc. They have a rich product line in the field of special balloons.
Peripheral and vascular access fields: The company is the first to obtain certification in Europe and achieve sales. Product performance and stability have been verified."